Genome wide expression profiling reveals suppression of host defence responses during colonisation by neisseria meningitides but not N. lactamica

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wong, Hazel En En ^a,b   Li, Ming Shi ^b   Kroll, J Simon ^b   Hibberd, Martin L ^a   Langford, Paul R ^b  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT COMPONENT C1S; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL SECRETION SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENERGY YIELD; EVOLUTIONARY ADAPTATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC ASSOCIATION; GENETIC SELECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LONG TERM EXPOSURE; LUNG ALVEOLUS EPITHELIUM; MENINGOCOCCOSIS; MICROARRAY ANALYSIS; MONOLAYER CULTURE; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; SPECIES DIFFERENTIATION; UPREGULATION; ADAPTATION; BRONCHUS; CELL LINE; CYTOLOGY; CYTOPLASM; ENERGY METABOLISM; EPITHELIUM CELL; GENETICS; GENOMICS; IMMUNITY; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY; SECRETION; SPECIES DIFFERENCE; TIME;

BACTERIA (MICROORGANISMS); NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS;

ADAPTATION, PHYSIOLOGICAL; BACTERIAL PROTEINS; BRONCHI; CELL LINE; COMPLEMENT C1S; CYTOKINES; CYTOPLASM; DOWN-REGULATION; ENERGY METABOLISM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; IMMUNITY; INFLAMMATION MEDIATORS; MICROBIAL VIABILITY; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; SPECIES SPECIFICITY; TIME FACTORS; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054787199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026130     Document Type: Article

References (66)

1. Serruto D, Adu-Bobie J, Capecchi B, Rappuoli R, Pizza M, et al. (2004) Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. J Biotechnol 113: 15-32.
2. Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M, (1978) Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 137: 112-121.
3. Olsen SF, Djurhuus B, Rasmussen K, Joensen HD, Larsen SO, et al. (1991) Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect 106: 445-457.
4. Caugant DA, Maiden MC, (2009) Meningococcal carriage and disease-population biology and evolution. Vaccine 27 (Suppl 2): B64-70.
5. Evans CM, Pratt CB, Matheson M, Vaughan TE, Findlow J, et al. (2011) Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis. Clin Infect Dis 52: 70-77.
6. Pujol C, Eugene E, de Saint Martin L, Nassif X, (1997) Interaction of Neisseria meningitidis with a polarized monolayer of epithelial cells. Infect Immun 65: 4836-4842.
7. Bennett JS, Bentley SD, Vernikos GS, Quail MA, Cherevach I, et al. (2010) Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06. BMC Genomics 11: 652.
8. Read RC, Zimmerli S, Broaddus C, Sanan DA, Stephens DS, et al. (1996) The (alpha2->8)-linked polysialic acid capsule of group B Neisseria meningitidis modifies multiple steps during interaction with human macrophages. Infect Immun 64: 3210-3217.
9. Schneider MC, Exley RM, Ram S, Sim RB, Tang CM, (2007) Interactions between Neisseria meningitidis and the complement system. Trends Microbiol 15: 233-240.
10. Virji M, (1996) Meningococcal disease: epidemiology and pathogenesis. Trends Microbiol 4: 466-469; discussion 469-470.
11. Hammerschmidt S, Hilse R, van Putten JP, Gerardy-Schahn R, Unkmeir A, et al. (1996) Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. Embo J 15: 192-198.
12. Virji M, Saunders JR, Sims G, Makepeace K, Maskell D, et al. (1993) Pilus-facilitated adherence of Neisseria meningitidis to human epithelial and endothelial cells: modulation of adherence phenotype occurs concurrently with changes in primary amino acid sequence and the glycosylation status of pilin. Mol Microbiol 10: 1013-1028.
13. Schubert-Unkmeir A, Slanina H, Frosch M, (2009) Mammalian cell transcriptome in response to meningitis-causing pathogens. Expert Rev Mol Diagn 9: 833-842.
14. Bonnah RA, Muckenthaler MU, Carlson H, Minana B, Enns CA, et al. (2004) Expression of epithelial cell iron-related genes upon infection by Neisseria meningitidis. Cell Microbiol 6: 473-484.
15. Plant L, Asp V, Lovkvist L, Sundqvist J, Jonsson AB, (2004) Epithelial cell responses induced upon adherence of pathogenic Neisseria. Cell Microbiol 6: 663-670.
16. Linhartova I, Basler M, Ichikawa J, Pelicic V, Osicka R, et al. (2006) Meningococcal adhesion suppresses proapoptotic gene expression and promotes expression of genes supporting early embryonic and cytoprotective signaling of human endothelial cells. FEMS Microbiol Lett 263: 109-118.
17. Schubert-Unkmeir A, Sokolova O, Panzner U, Eigenthaler M, Frosch M, (2007) Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis. Infect Immun 75: 899-914.
18. Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, et al. (2004) Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 363: 203-209.
19. Wells DB, Tighe PJ, Wooldridge KG, Robinson K, Ala' Aldeen DA, (2001) Differential gene expression during meningeal-meningococcal interaction: evidence for self-defense and early release of cytokines and chemokines. Infect Immun 69: 2718-2722.
20. Robinson K, Taraktsoglou M, Rowe KS, Wooldridge KG, Ala'Aldeen DA, (2004) Secreted proteins from Neisseria meningitidis mediate differential human gene expression and immune activation. Cell Microbiol 6: 927-938.
21. Liu X, Wetzler LM, Nascimento LO, Massari P, (2010) Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling. Infect Immun 78: 5314-5323.
22. Tezera L, Hampton J, Jackson S, Davenport V, (2010) Neisseria lactamica attenuates TLR 1/2- induced cytokine responses in nasopharyngeal epithelial cells using PPAR-gamma. Cell Microbiol.
23. Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, et al. (2002) Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development. Ann N Y Acad Sci 975: 202-216.
24. Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, et al. (2002) Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol 20: 914-921.
25. Chamot-Rooke J, Mikaty G, Malosse C, Soyer M, Dumont A, et al. (2011) Posttranslational modification of pili upon cell contact triggers N. meningitidis dissemination. Science 331: 778-782.
26. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, et al. (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287: 1809-1815.
27. Gorringe AR, Taylor S, Brookes C, Matheson M, Finney M, et al. (2009) Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Clin Vaccine Immunol 16: 1113-1120.
28. Vaughan TE, Skipp PJ, O'Connor CD, Hudson MJ, Vipond R, et al. (2006) Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens. Vaccine 24: 5277-5293.
29. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, et al. (2006) Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34: W645-650.
30. Mukhopadhyay TK, Halliwell D, O'Dwyer C, Shamlou PA, Levy MS, et al. (2005) Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine. Biotechnol Appl Biochem 41: 175-182.
31. Dietrich G, Kurz S, Hubner C, Aepinus C, Theiss S, et al. (2003) Transcriptome analysis of Neisseria meningitidis during infection. J Bacteriol 185: 155-164.
32. Baart GJ, Langenhof M, van de Waterbeemd B, Hamstra HJ, Zomer B, et al. (2010) Expression of phosphofructokinase in Neisseria meningitidis. Microbiology 156: 530-542.
33. McNeil LK, Reich C, Aziz RK, Bartels D, Cohoon M, et al. (2007) The National Microbial Pathogen Database Resource (NMPDR): a genomics platform based on subsystem annotation. Nucleic Acids Res 35: D347-353.
34. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI, (1999) A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A 96: 9833-9838.
35. Fowler MI, Yin KY, Humphries HE, Heckels JE, Christodoulides M, (2006) Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis. Infect Immun 74: 6467-6478.
36. van Deuren M, Brandtzaeg P, van der Meer JW, (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13: 144-166.
37. Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, et al. (2006) Functional significance of factor H binding to Neisseria meningitidis. J Immunol 176: 7566-7575.
38. Schneider MC, Prosser BE, Caesar JJ, Kugelberg E, Li S, et al. (2009) Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458: 890-893.
39. Reigstad CS, Hultgren SJ, Gordon JI, (2007) Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem 282: 21259-21267.
40. Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM, (1999) Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett 452: 309-313.
41. Meyer-Hoffert U, Wichmann N, Schwichtenberg L, White PC, Wiedow O, (2003) Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes. Exp Dermatol 12: 418-425.
42. Vos JB, van Sterkenburg MA, Rabe KF, Schalkwijk J, Hiemstra PS, et al. (2005) Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense. Physiol Genomics 21: 324-336.
43. Higashimoto Y, Yamagata Y, Iwata T, Ishiguchi T, Okada M, et al. (2005) Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells. Respiration 72: 629-635.
44. Bergman P, Johansson L, Asp V, Plant L, Gudmundsson GH, et al. (2005) Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol 7: 1009-1017.
45. Zhou L, Tan A, Hershenson MB, (2004) Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells. Respir Physiol Neurobiol 140: 89-97.
46. Beisswenger C, Coyne CB, Shchepetov M, Weiser JN, (2007) Role of p38 MAP kinase and transforming growth factor-beta signaling in transepithelial migration of invasive bacterial pathogens. J Biol Chem 282: 28700-28708.
47. Wick M, Burger C, Funk M, Muller R, (1995) Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation. Exp Cell Res 219: 527-535.
48. Fiorentino L, Pertica C, Fiorini M, Talora C, Crescenzi M, et al. (2000) Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol Cell Biol 20: 7735-7750.
49. Makkinje A, Quinn DA, Chen A, Cadilla CL, Force T, et al. (2000) Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress. J Biol Chem 275: 17838-17847.
50. Monick MM, Cameron K, Staber J, Powers LS, Yarovinsky TO, et al. (2005) Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem 280: 2147-2158.
51. Zhang X, Pickin KA, Bose R, Jura N, Cole PA, et al. (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450: 741-744.
52. O'Grady E, Mulcahy H, Adams C, Morrissey JP, O'Gara F, (2007) Manipulation of host Kruppel-like factor (KLF) function by exotoxins from diverse bacterial pathogens. Nat Rev Microbiol 5: 337-341.
53. Exley RM, Sim R, Goodwin L, Winterbotham M, Schneider MC, et al. (2009) Identification of meningococcal genes necessary for colonization of human upper airway tissue. Infect Immun 77: 45-51.
54. O'Dwyer CA, Reddin K, Martin D, Taylor SC, Gorringe AR, et al. (2004) Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential. Infect Immun 72: 6511-6518.
55. Blake MS, MacDonald CM, Klugman KP, (1989) Colony morphology of piliated Neisseria meningitidis. J Exp Med 170: 1727-1736.
56. van Ulsen P, Tommassen J, (2006) Protein secretion and secreted proteins in pathogenic Neisseriaceae. FEMS Microbiol Rev 30: 292-319.
57. Virji M, Kayhty H, Ferguson DJ, Alexandrescu C, Heckels JE, et al. (1991) The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol Microbiol 5: 1831-1841.
58. Virji M, Makepeace K, Peak IR, Ferguson DJ, Jennings MP, et al. (1995) Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol Microbiol 18: 741-754.
59. Uronen-Hansson H, Steeghs L, Allen J, Dixon GL, Osman M, et al. (2004) Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production. Cell Microbiol 6: 625-637.
60. Gruenert DC, Finkbeiner WE, Widdicombe JH, (1995) Culture and transformation of human airway epithelial cells. Am J Physiol 268: L347-360.
61. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, et al. (1994) CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38-47.
62. Li MS, Chow NY, Sinha S, Halliwell D, Finney M, et al. (2009) A Neisseria meningitidis NMB1966 mutant is impaired for invasion of respiratory epithelial cells, survival in human blood and for virulence in vivo. Med Microbiol Immunol 198: 57-67.
63. Hartman AL, Ling L, Nichol ST, Hibberd ML, (2008) Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J Virol 82: 5348-5358.
64. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
65. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
66. Mukhopadhyay TK, (2008) (2008) Rapid vaccine development using a micro-scale platform [Doctoral Thesis]: University of London.